Healthcare provider profile · identity verified

John Swan, MD

Family Practice · VANCOUVER, WA · NPI 1770504482

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	740	219
Amlodipine Besylate	Amlodipine Besylate	612	166
Losartan Potassium	Losartan Potassium	543	153
Rosuvastatin Calcium	Rosuvastatin Calcium	410	128
Levothyroxine Sodium	Levothyroxine Sodium	308	92
Metformin Hcl	Metformin Hcl	286	86
Lisinopril	Lisinopril	264	75
Omeprazole	Omeprazole	228	66
Alendronate Sodium	Alendronate Sodium	218	69
Pantoprazole Sodium	Pantoprazole Sodium	195	55
Metoprolol Tartrate	Metoprolol Tartrate	188	54
Gabapentin	Gabapentin	182	51
Trazodone Hcl	Trazodone Hcl	172	49
Tamsulosin Hcl	Tamsulosin Hcl	166	53
Eliquis	Apixaban	157	41
Spironolactone	Spironolactone	157	49
Metoprolol Succinate	Metoprolol Succinate	150	48
Furosemide	Furosemide	139	34
Potassium Chloride	Potassium Chloride	135	38
Clopidogrel	Clopidogrel Bisulfate	129	35
Simvastatin	Simvastatin	122	27
Ezetimibe	Ezetimibe	107	37
Allopurinol	Allopurinol	103	34
Duloxetine Hcl	Duloxetine Hcl	102	23
Pravastatin Sodium	Pravastatin Sodium	96	25
Mounjaro	Tirzepatide	94	14
Carvedilol	Carvedilol	86	24
Ozempic	Semaglutide	80	17
Ipratropium Bromide	Ipratropium Bromide	72	33
Sertraline Hcl	Sertraline Hcl	68	19
Clonidine Hcl	Clonidine Hcl	64	21
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	26
Lamotrigine	Lamotrigine	59	17
Metformin Hcl Er	Metformin Hcl	59	17
Citalopram Hbr	Citalopram Hydrobromide	56	15
Famotidine	Famotidine	55	16
Donepezil Hcl	Donepezil Hcl	54	15
Nitroglycerin	Nitroglycerin	54	38
Eplerenone	Eplerenone	52	11
Januvia	Sitagliptin Phosphate	51	suppressed
Glimepiride	Glimepiride	49	13
Oxycodone Hcl	Oxycodone Hcl	49	19
Trulicity	Dulaglutide	49	12
Labetalol Hcl	Labetalol Hcl	48	14
Escitalopram Oxalate	Escitalopram Oxalate	47	12
Cilostazol	Cilostazol	46	suppressed
Mirtazapine	Mirtazapine	45	13
Warfarin Sodium	Warfarin Sodium	44	suppressed
Clonazepam	Clonazepam	42	suppressed
Fenofibrate	Fenofibrate	42	13
Finasteride	Finasteride	39	13
Propranolol Hcl	Propranolol Hcl	39	13
Atenolol	Atenolol	38	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	18
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Estradiol	Estradiol	34	17
Lorazepam	Lorazepam	33	18
Montelukast Sodium	Montelukast Sodium	33	suppressed
Mupirocin	Mupirocin	33	21
Testosterone	Testosterone	33	suppressed
Baclofen	Baclofen	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	32	16
Jardiance	Empagliflozin	31	suppressed
Torsemide	Torsemide	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Prednisone	Prednisone	29	22
Zolpidem Tartrate	Zolpidem Tartrate	29	15
Acyclovir	Acyclovir	28	suppressed
Repatha Sureclick	Evolocumab	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Hydrochlorothiazide	Hydrochlorothiazide	25	suppressed
Meloxicam	Meloxicam	25	12
Azelastine Hcl	Azelastine Hcl	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Glipizide	Glipizide	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Methadone Hcl	Methadone Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Telmisartan	Telmisartan	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	16
Bupropion Hcl	Bupropion Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Clotrimazole	Clotrimazole	20	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Latanoprost	Latanoprost	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Cephalexin	Cephalexin	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Topiramate	Topiramate	16	suppressed
Alprazolam	Alprazolam	15	11
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Diazepam	Diazepam	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Risperidone	Risperidone	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Temazepam	Temazepam	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Clomipramine Hcl	Clomipramine Hcl	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Colchicine	Colchicine	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error